BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19896404)

  • 1. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors.
    Diarra A; Kouriba B; Baby M; Murphy E; Lefrere JJ
    Transfus Clin Biol; 2009; 16(5-6):444-7. PubMed ID: 19896404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt.
    El-Gilany AH; El-Fedawy S
    East Mediterr Health J; 2006 Nov; 12(6):742-8. PubMed ID: 17333818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
    Mutlu B; Meriç M; Willke A
    Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative safety of first-time volunteer and replacement donors in West Africa.
    Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
    Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa.
    Nagalo BM; Bisseye C; Sanou M; Kienou K; Nebié YK; Kiba A; Dahourou H; Ouattara S; Nikiema JB; Moret R; Zongo JD; Simpore J
    Trop Med Int Health; 2012 Feb; 17(2):247-53. PubMed ID: 21988100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience.
    Sultan F; Mehmood T; Mahmood MT
    Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.
    Kania D; Sangaré L; Sakandé J; Koanda A; Nébié YK; Zerbo O; Combasséré AW; Guissou IP; Rouet F
    Transfusion; 2009 Oct; 49(10):2237-40. PubMed ID: 19903285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
    J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.